Delivery Order SPE2DB22D3301-SPE2DB25FY7XD
Award Date 7/16/25
Potential Completion Date 7/17/25
Potential Value $6.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML medical products. The contract has a ceiling value of $3,034.60 and a period of performance ending on July 9, 2025. This award is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp also holds a significant $999,999,999.00...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract has a ceiling value of $28,488.57 and an ultimate completion date of May 19, 2025. The award is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, with a ceiling value of $4,938.36 and a performance period extending through May 13, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with a ceiling value of $12,437.90. The contract has a firm fixed price pricing type and an ultimate completion date of June 24, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The contract has a firm fixed price and a ceiling value of $20,697.00, with a period of performance ending on June 11, 2025. The award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,726.60 and a completion date of June 24, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with a ceiling value of $11,038.40. The contract is a firm fixed-price, non-set-aside delivery order with a performance period ending on July 1, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,449.50, is for the supply of 4566910428 - TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, with a period of performance ending on January 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML medical supplies. The contract has a firm fixed price of $3,449.50 and a completion date of June 5, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract has a ceiling value of $43,164.50 and is a firm fixed price delivery order with a completion date of March 25, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY7XDDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The contract has a ceiling value of $6,278.09 and a period of performance ending on July 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and running through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle, enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Generated 10/15/25, 9:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 7/16/25 |